NCT05170126View on ClinicalTrials.gov

A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring

RecruitingOBSERVATIONAL
Enrollment

1,182

Participants

Timeline

Start Date

August 8, 2022

Primary Completion Date

June 30, 2032

Study Completion Date

June 30, 2032

Conditions
Multiple Sclerosis
Trial Locations (3)

44625

RECRUITING

Marienhospital Herne, Klinikum Der Ruhr-Universitaet Bochum, Herne

28401-3331

RECRUITING

ZEPOSIA MS Pregnancy Registry, Wilmington

RECRUITING

ZEPOSIA MS Pregnancy Registry, Wilmington

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY